Table 2.
Locations of lesions in patients undergoing percataneous and surgical radiofrequency ablation
|
RFA |
||
| Percataneous (n = 89) | Surgical (n = 108) | |
| Segment location | ||
| I | 0 | 0 |
| II | 7 | 12 |
| III | 13 | 17 |
| IV | 9 | 12 |
| V | 10 | 14 |
| VI | 6 | 11 |
| VII | 12 | 20 |
| VIII | 12 | 7 |
| Adjacent vessels or organs | ||
| PH | 8 | 12 |
| RHV | 17 | 15 |
| MHV | 8 | 12 |
| LHV | 11 | 16 |
| IVC | 6 | 8 |
| Heart | 3 | 5 |
| Stomach | 9 | 17 |
| Lung | 15 | 2 |
| R.Kidney | 4 | 7 |
| Colon | 5 | 12 |
| GB | 3 | 2 |
P = 0.640 by Pearson χ2 test for segment location and P = 0.054 by Pearson χ2 test for adjacent vessels or organs. Lesion between segments was registered at the major location. n: Lesion number; RFA: Radiofrequency ablation; PH: Porta hepatis; RHV: Right hepatic vein; MHV: Middle hepatic vein; LHV: Left hepatic vein; IVC: Inferior vena cava; GB: Gall bladder.